Corrigendum to “PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging” [Biomaterials 34 (2013) 9666–9677/ pubmed: 24034498, (S0142961213010120), (10.1016/j.biomaterials.2013.08.049)];PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9666-9677

  Shi, Jinjin ^a   Yu, Xiaoyuan ^a   Wang, Lei ^a   Liu, Yan ^a   Gao, Jun ^a   Zhang, Jing ^a   Ma, Rou ^a   Liu, Ruiyuan ^a   Zhang, Zhenzhong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Bioimaging; Fullerene; Iron oxide; Magnetic targeting; Photodynamic therapy

Indexed keywords

BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; DISEASES; FULLERENES; MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOCOMPOSITES; PHOTODYNAMIC THERAPY; TARGETED DRUG DELIVERY; TUMORS;

BIO-IMAGING; FULLERENE C60; FULLERENE DERIVATIVE; HEMATOPORPHYRIN MONOMETHYL ETHER; IN-VIVO; MAGNETIC TARGETING; MR IMAGING; OXIDE NANOPARTICLES; PEGYLATED; PHYSICAL AND CHEMICAL PROPERTIES;

IRON OXIDES;

FULLERENE; FULLERENE DERIVATIVE; HEMATOPORPHYRIN; HEMATOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN MONOMETHYL ETHER; IRON OXIDE; IRON OXIDE NANOPARTICLE; MACROGOL; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIOMEDICINE; CANCER CELL; CANCER THERAPY; COMPARATIVE STUDY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG TARGETING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SOLUBILITY; TUMOR MODEL;

MURINAE;

BIOIMAGING; FULLERENE; IRON OXIDE; MAGNETIC TARGETING; PHOTODYNAMIC THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; FERRIC COMPOUNDS; FULLERENES; HEMATOPORPHYRINS; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; NANOCOMPOSITES; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS;

EID: 84884816888     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2023.122343     Document Type: Erratum

References (45)

1. Gomaa I., Ali S.E., El-Tayeb T.A., Abdel-kader M.H. Chlorophyll derivative mediated PDT versus methotrexate: an invitro study using MCF-7 cells. Photodiagnosis Photodyn Ther 2012, 9:362-368.
2. Bozzini G., Colin P., Betrouni N., Nevoux P., Ouzzane A., Puech P., et al. Photodynamic therapy in urology: what can we do now and where are we heading?. Photodiagnosis Photodyn Ther 2012, 9:261-273.
3. Tian G., Ren W., Yan L., Jian S., Gu Z., Zhou L., et al. Red-emitting upconverting nanoparticles for photodynamic therapy in cancer cells under near-infrared excitation. Small 2013, 9:1929-1938.
4. Cui S., Yin D., Chen Y., Di Y., Chen H., Ma Y., et al. Invivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. ACS Nano 2013, 7:676-688.
5. Huang P., Lin J., Wang X., Wang Z., Zhang C., He M., et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 2012, 24:5104-5110.
6. Obaid G., Chambrier I., Cook M.J., Russell D.A. Targeting the oncofetal Thomsen-Friedenreich disaccharide using jacalin-PEG phthalocyanine gold nanoparticles for photodynamic cancer therapy. Angew Chem Int Ed Engl 2012, 51:6158-6162.
7. Juarranz A., Jaen P., Sanz-Rodriguez F., Cuevas J., Gonzalez S. Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 2008, 10:148-154.
8. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010, 110:2795-2838.
9. Detty M.R., Gibson S.L., Wagner S.J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. JMed Chem 2004, 47:3897-3915.
10. Benachour H., Seve A., Bastogne T., Frochot C., Vanderesse R., Jasniewski J., et al. Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics 2012, 2:889-904.
11. Bovis M.J., Woodhams J.H., Loizidou M., Scheglmann D., Bown S.G., Macrobert A.J. Improved invivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. JControl Release 2012, 157:196-205.
12. Barth B.M., I Altinoǧlu E., Shanmugavelandy S.S., Kaiser J.M., Crespo-Gonzalez D., DiVittore N.A., et al. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for invivo photodynamic therapy of leukemia. ACS Nano 2011, 5:5325-5337.
13. Maeda H., Matsumura Y. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. Adv Drug Deliv Rev 2011, 63:129-130.
14. Shi J., Zhang H., Wang L., Li L., Wang H., Wang Z., et al. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials 2013, 34:251-261.
15. Montellano A., Da Ros T., Bianco A., Prato M. Fullerene C(6)(0) as a multifunctional system for drug and gene delivery. Nanoscale 2011, 3:4035-4041.
16. Shi J., Wang Z., Wang L., Wang H., Li L., Yu X., et al. Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer. Int J Nanomedicine 2013, 8:1551-1562.
17. Chaudhuri P., Paraskar A., Soni S., Mashelkar R.A., Sengupta S. Fullerenol-cytotoxic conjugates for cancer chemotherapy. ACS Nano 2009, 3:2505-2514.
18. Fan J., Fang G., Zeng F., Wang X., Wu S. Water-dispersible fullerene aggregates as a targeted anticancer prodrug with both chemo- and photo-dynamic therapeutic actions. Small 2013, 9:613-621.
19. Chen Z., Ma L., Liu Y., Chen C. Applications of functionalized fullerenes in tumor theranostics. Theranostics 2012, 2:238-250.
20. Zhen M., Zheng J., Ye L., Li S., Jin C., Li K., et al. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene. ACS Appl Mater Interfaces 2012, 4:3724-3729.
21. Liu J., Ohta S., Sonoda A., Yamada M., Yamamoto M., Nitta N., et al. Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. JControl Release 2007, 117:104-110.
22. Milanesio M.E., Alvarez M.G., Rivarola V., Silber J.J., Durantini E.N. Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitizers for photodynamic therapy. Photochem Photobiol 2005, 81:891-897.
23. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995, 55:3752-3756.
24. Charrois G.J., Allen T.M. Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta 2003, 1609:102-108.
25. van Nostrum C.F. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:9-16.
26. Bugaj A.M. Targeted photodynamic therapy-a promising strategy of tumor treatment. Photochem Photobiol Sci 2011, 10:1097-1109.
27. Schmitt F., Lagopoulos L., Kauper P., Rossi N., Busso N., Barge J., et al. Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. JControl Release 2010, 144:242-250.
28. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. JAm Chem Soc 2003, 125:7860-7865.
29. Riegler J., Wells J.A., Kyrtatos P.G., Price A.N., Pankhurst Q.A., Lythgoe M.F. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 2010, 31:5366-5371.
30. Kato T., Nemoto R., Mori H., Abe R., Unno K., Goto A., et al. Magnetic microcapsules for targeted delivery of anticancer drugs. Appl Biochem Biotechnol 1984, 10:199-211.
31. Zhang J., Misra R.D. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response. Acta Biomater 2007, 3:838-850.
32. Fu A., Wilson R.J., Smith B.R., Mullenix J., Earhart C., Akin D., et al. Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects. ACS Nano 2012, 6:6862-6869.
33. Hassan E.E., Gallo J.M. Targeting anticancer drugs to the brain. I: enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. JDrug Target 1993, 1:7-14.
34. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.T., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
35. Huang P., Li Z., Lin J., Yang D., Gao G., Xu C., et al. Photosensitizer-conjugated magnetic nanoparticles for invivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials 2011, 32:3447-3458.
36. Xinxing Ma H.T., Yang Kai, Feng Liangzhu, Cheng Liang, Shi Xiaoze, Li Yonggang, et al. Afunctionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res 2012, 5:199-212.
37. Sun H.M., Cao L.Y., Lu L.H. Magnetite/reduced graphene oxide nanocomposites: one step solvothermal synthesis and use as a novel platform for removal of dye pollutants. Nano Res 2011, 4:550-562.
38. Shi X., Gong H., Li Y., Wang C., Cheng L., Liu Z. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials 2013, 34:4786-4793.
39. Girard O.M., Ramirez R., McCarty S., Mattrey R.F. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Contrast Media Mol Imaging 2012, 7:411-417.
40. Cai H., Gu Y., Zeng J., Li S.R., Wang Y., Shi D.W., et al. Effect of HMME-PDT on hyperplastic scar in rabbit ear model. Zhonghua Zheng Xing Wai Ke Za Zhi 2007, 23:425-427.
41. Zhao T., Shen X., Li L., Guan Z., Gao N., Yuan P., et al. Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy. Nanoscale 2012, 4:7712-7719.
42. Gandra N., Abbineni G., Qu X., Huai Y., Wang L., Mao C. Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy. Small 2013, 9:215-221.
43. Huang P., Xu C., Lin J., Wang C., Wang X., Zhang C., et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1:240-250.
44. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5:7000-7009.
45. Shi J., Ma R., Wang L., Zhang J., Liu R., Li L., et al. The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for invivo and invitro cancer treatment. Int J Nanomedicine 2013, 8:2361-2373.